bpc 157 experience The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety What Is BPC-157? The Body

Yoshii K, Hosomi K, Sawane K, et al

Some people dont produce enough intrinsic factors, and they also can become deficient

Biorg Med Chem 25:61806189 Bekaii-Saab T, Wesolowski R, Ahn DH, Wu C, Mortazavi A, Lustberg M, Ramaswamy B, Fowler J, Wei L et al (2019) Phase I immunotherapy trial with two chimeric HER-2 B-cell peptide vaccines emulsified in montanide ISA 720VG and nor-MDP adjuvant in patients with advanced solid tumors phase I immunotherapy trial with two B-cell vaccines

The trial was marked as completed, but results were never published the submission was cancelled in 2016 with no explanation provided in the public record [18]